Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pehuaxihaimapeptide Injection in Hemodialysis-Related Anemia
CTR20140533Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Jan 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of pehuaxihaimapeptide in anaemia, sponsored by Hengrui Therapeutics. Started Jan 2015; status: completed.
02
Drugs
pehuaxihaimapeptide
03
Conditions
anaemia
Beyond the preview
Go deeper on CTR20140533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140533.